San Donato Hospital
Adenocarcinoma treatment cost in Italy typically includes diagnostic Histopathology revision ranging from $200 to $400 and primary interventions like lung cancer surgery, which runs from $30,000 to $50,000. Total expenses depend on the cancer stage, organ affected, and chosen surgical approach. International patients can find 10-25% savings compared to Western Europe. Milan and Rome are the top cities for this treatment.
Typical Adenocarcinoma Treatment Costs in Italy
Bookimed Expert Insight: Patients requiring complex oncological care benefit from Milan's IRCCS-accredited research hospitals. San Raffaele is best for advanced cases needing multidisciplinary surgical expertise. They perform over 52,000 operations annually with high robotic precision. For those prioritizing research-driven protocols, San Donato offers top-tier academic clinical environments. These facilities provide higher value than standard private clinics for aggressive adenocarcinoma stages.
| Italy | Turkey | Austria | |
| Whipple surgery | from $35,000 | from $23,000 | from $45,000 |
| Uterine Trachelectomy | from $12,000 | from $5,500 | from $14,500 |
| Robotic da Vinci prostatectomy | from $24,875 | from $17,000 | from $20,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $7,000 | from $12,000 |
| Proton-beam therapy | from $70,000 | from $70,000 | from $80,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Adenocarcinoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Adenocarcinoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Adenocarcinoma treatment journey.
The doctor is an Italian expert in breast cancer treatment with over 20 years of practice, specializing in breast and lymph node preservation. As one of the most experienced professionals at the European Institute of Oncology, the doctor heads the Breast Unit at San Raffaele Hospital. The doctor has performed over 5,000 breast cancer surgeries and is a leader in preventive procedures for women with high genetic risks of breast cancer.
Since 2016, the doctor has been the Head of the Research Unit in the Breast Cancer Surgery Department at San Raffaele Hospital and leads the SOUND study at the European Institute of Oncology. The doctor has authored over 100 papers on breast tumor treatment and focuses on breast cancer management in young women and pregnant patients.
Top hospitals in Italy for adenocarcinoma include the European Institute of Oncology (IEO) and San Raffaele Hospital in Milan. These centers hold Scientific Institute for Research and Healthcare (IRCCS) accreditation. They offer advanced therapies like HIPEC, robotic surgery, and proton beam radiation for various tumor types.
Bookimed Expert Insight: Milan serves as the primary hub for complex adenocarcinoma due to the concentration of IRCCS-accredited hospitals. San Raffaele and San Donato both treat 300,000 patients annually. This high volume allows surgeons to maintain specialized skills in rare tumor subtypes that smaller regional clinics may see less frequently.
Patient Consensus: Patients emphasize choosing northern institutes for higher surgical volumes and clinical trials. They note that private options help bypass the 3-6 month waitlists common in the public system.
Italy offers advanced immunotherapy and robotic surgery for adenocarcinoma at major research hospitals. Leading centers utilize da Vinci robotic systems for thoracic and abdominal procedures. Targeted immunotherapy drugs like pembrolizumab are standard for lung and gastric cases. These therapies are widely available in Northern medical hubs.
Bookimed Expert Insight: Italian oncology centers like San Raffaele are unique because they hold IRCCS accreditation. This status means they legally must combine clinical care with active research. For patients, this translates to faster access to experimental protocols. These centers perform over 52,000 operations annually, ensuring high surgical proficiency in complex robotic cases.
Patient Consensus: Patients note that molecular profiling is vital for accessing immunotherapy early. While northern hubs like Milan offer excellent robotics, some find the administrative process for certain treatments takes time.
Italian surgical teams are highly specialized through mandatory OECI accreditation and multidisciplinary tumor boards. Centers like San Raffaele perform over 52,000 operations annually. They utilize robotic-assisted systems like da Vinci for complex gastrointestinal, thoracic, and urologic adenocarcinomas to preserve healthy tissue and improve recovery.
Bookimed Expert Insight: While many countries offer general oncology, Italy's IRCCS-accredited hospitals like San Raffaele and San Donato operate under direct Ministry of Health oversight. This designation ensures surgeons handle extreme patient volumes, with San Raffaele managing 300,000 patients yearly. This volume leads to rare proficiency in complex adenocarcinomas that smaller European clinics may see less frequently.
Patient Consensus: Patients note that while surgical expertise in Milan and Rome is world-class, non-EU residents should prepare for significant administrative paperwork. Many emphasize the value of high-volume centers where surgeons have performed over 1,000 robotic resections.
Italian private hospitals frequently accept international insurance for cancer care through direct or indirect billing agreements. Facilities like UPMC Salvator Mundi in Rome partner with over 50 insurers. These include Aetna, Allianz, Bupa, and Cigna. Most hospitals require pre-authorization before treatment.
Bookimed Expert Insight: Italian private centers like San Raffaele handle over 52,000 operations annually. Many hold IRCCS accreditation for combining research with clinical care. While these centers are prestigious, patients often face 100% upfront payment requirements for oncology. You should secure a local fiscal code early to streamline the reimbursement process. This step often helps in recovering 60% to 90% of your total out-of-pocket costs.
Patient Consensus: Patients note that direct billing is rare and typically require at least a 30% deposit upfront. They emphasize starting the pre-approval process with insurers at least 2 months before traveling for treatment.
During a first oncology consultation in Italy, prioritize discussing tumor staging, genetic profiling, and the specific multidisciplinary treatment plan. Inquire about clinical trials and molecular testing for targeted therapies. Ensure you understand your rights under Italian law, including privacy and oncological right to be forgotten.
Bookimed Expert Insight: While many choose famous research hospitals like San Raffaele for its 52,000 annual surgeries, regional location significantly impacts access. Data shows that specialized IRCCS centers combine clinical care with intensive research. This often provides faster access to advanced diagnostics like PET/CT scans compared to general regional hospitals. Patients should ask if their facility holds IRCCS accreditation to ensure they receive research-backed treatment protocols.
Patient Consensus: Patients often regret not asking for written treatment timelines immediately. They also emphasize that requesting a second opinion at a national cancer institute in northern Italy can reveal different trial options or shorter wait times for surgery.
Psychological support is mandated by AIOM guidelines but implementation varies across Italian regions. Specialized research hospitals (IRCCS) in Milan and Bologna provide integrated psychosocial care. However, only 34% of Italian Breast Units currently have onsite psycho-oncologists. Patients must often request these services explicitly.
Bookimed Expert Insight: While small regional clinics may lack staff, Italy's IRCCS-accredited centers like San Raffaele combine research with clinical care. These high-volume centers performing over 52,000 operations annually prioritize holistic recovery. Patients should prioritize Milan or Bologna for integrated adenocarcinoma treatment teams.
Patient Consensus: Patients note that support is not automatic and waits can reach 3 months. Many recommend asking for a referral at diagnosis to avoid burnout and paying private fees.
Patients in Italy use the AIMaC national helpline and the OncoGuida portal for navigation. Major research centers like San Raffaele in Milan provide integrated research and clinical care. Local health units (ASL) offer fast-track diagnostic pathways called Percorso Terapeutico Diagnostico to prioritize cancer cases.
Bookimed Expert Insight: Italian IRCCS-accredited hospitals like San Raffaele and San Donato combine research with volume. San Raffaele performs over 52,000 operations annually across major oncology specialties. This high patient volume often correlates with faster access to innovative clinical trials. Patients should choose IRCCS centers to ensure treatment aligns with the latest research.
Patient Consensus: Patients emphasize using local ASL websites to check eligibility for fast-track diagnostic pathways. They also note that the Croce Rossa provides essential transport support when mobility is limited.